Russia Approves Oncophage For Kidney Cancer Treatment

Armen Hareyan's picture
Advertisement

Antigenics Inc. (NASDAQ: AGEN) today announced that the Russian Ministry of Public Health has issued a registration certificate for the use of Oncophage

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.
Advertisement